Vioxx
Executive Summary
In September, rofecoxib had a 49.9% of new prescriptions in the COX-2 inhibitor market, Merck says
You may also be interested in...
Pharmacia To Launch Parecoxib With Zyvox Sales Force: No Partner Needed
Pharmacia plans to launch the injectable COX-2 inhibitor parecoxib using the hospital sales force that launched the antibiotic Zyvox (linezolid), Global Business Management President Carrie Cox said during an Oct. 30 earnings conference call.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011